XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 291,905 $ 229,902
Marketable securities 327,044 193,436
Total cash, cash equivalents, and marketable securities 618,949 423,338
Accounts receivable, net 191,987 300,173
Unbilled receivables, net 170,458 237,379
Other current assets 78,193 68,137
Total current assets 1,059,587 1,029,027
Long-term unbilled receivables, net 72,814 85,402
Goodwill 81,467 81,611
Other long-term assets 297,860 314,696
Total assets 1,511,728 1,510,736
Current liabilities:    
Accounts payable 6,353 11,290
Accrued expenses 80,642 39,941
Accrued compensation and related expenses 55,438 126,640
Deferred revenue 382,765 377,845
Convertible senior notes, net 499,985 0
Other current liabilities 19,096 21,343
Total current liabilities 1,044,279 577,059
Long-term convertible senior notes, net 0 499,368
Long-term operating lease liabilities 63,645 66,901
Other long-term liabilities 13,618 13,570
Total liabilities 1,121,542 1,156,898
Commitments and contingencies (Note 15)
Stockholders’ equity:    
Preferred stock, 1,000 shares authorized; none issued 0 0
Common stock, 200,000 shares authorized; 85,011 and 83,840 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 850 838
Additional paid-in capital 432,217 379,584
(Accumulated deficit) (20,829) (8,705)
Accumulated other comprehensive (loss) (22,052) (17,879)
Total stockholders’ equity 390,186 353,838
Total liabilities and stockholders’ equity $ 1,511,728 $ 1,510,736